Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis

PURPOSE: This meta-analysis aimed to assess the efficacy and safety of cyclin-dependent kinase (CDK) 4/6 inhibitors plus endocrine therapy (ET) in hormonal receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC). METHODS: We searched PubMed, Em...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jiani, Wu, Jingxun, Wang, Chunyue, Zhuang, Shiwen, Chen, Jianbo, Ye, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272037/
https://www.ncbi.nlm.nih.gov/pubmed/32497134
http://dx.doi.org/10.1371/journal.pone.0233571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272037/
https://www.ncbi.nlm.nih.gov/pubmed/32497134
http://dx.doi.org/10.1371/journal.pone.0233571

Ejemplares similares